These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

574 related items for PubMed ID: 25168343

  • 1. Estrogen metabolites and breast cancer.
    Santen RJ, Yue W, Wang JP.
    Steroids; 2015 Jul; 99(Pt A):61-6. PubMed ID: 25168343
    [Abstract] [Full Text] [Related]

  • 2. Genotoxic metabolites of estradiol in breast: potential mechanism of estradiol induced carcinogenesis.
    Yue W, Santen RJ, Wang JP, Li Y, Verderame MF, Bocchinfuso WP, Korach KS, Devanesan P, Todorovic R, Rogan EG, Cavalieri EL.
    J Steroid Biochem Mol Biol; 2003 Sep; 86(3-5):477-86. PubMed ID: 14623547
    [Abstract] [Full Text] [Related]

  • 3. Estrogen mediation of breast tumor formation involves estrogen receptor-dependent, as well as independent, genotoxic effects.
    Santen R, Cavalieri E, Rogan E, Russo J, Guttenplan J, Ingle J, Yue W.
    Ann N Y Acad Sci; 2009 Feb; 1155():132-40. PubMed ID: 19250200
    [Abstract] [Full Text] [Related]

  • 4. Tamoxifen versus aromatase inhibitors for breast cancer prevention.
    Yue W, Wang JP, Li Y, Bocchinfuso WP, Korach KS, Devanesan PD, Rogan E, Cavalieri E, Santen RJ.
    Clin Cancer Res; 2005 Jan 15; 11(2 Pt 2):925s-30s. PubMed ID: 15701888
    [Abstract] [Full Text] [Related]

  • 5. Catechol estrogen quinones as initiators of breast and other human cancers: implications for biomarkers of susceptibility and cancer prevention.
    Cavalieri E, Chakravarti D, Guttenplan J, Hart E, Ingle J, Jankowiak R, Muti P, Rogan E, Russo J, Santen R, Sutter T.
    Biochim Biophys Acta; 2006 Aug 15; 1766(1):63-78. PubMed ID: 16675129
    [Abstract] [Full Text] [Related]

  • 6. Effects of estrogen on breast cancer development: Role of estrogen receptor independent mechanisms.
    Yue W, Wang JP, Li Y, Fan P, Liu G, Zhang N, Conaway M, Wang H, Korach KS, Bocchinfuso W, Santen R.
    Int J Cancer; 2010 Oct 15; 127(8):1748-57. PubMed ID: 20104523
    [Abstract] [Full Text] [Related]

  • 7. The potential of aromatase inhibitors in breast cancer prevention.
    Santen RJ, Yue W, Naftolin F, Mor G, Berstein L.
    Endocr Relat Cancer; 1999 Jun 15; 6(2):235-43. PubMed ID: 10731115
    [Abstract] [Full Text] [Related]

  • 8. The effect of second-line antiestrogen therapy on breast tumor growth after first-line treatment with the aromatase inhibitor letrozole: long-term studies using the intratumoral aromatase postmenopausal breast cancer model.
    Long BJ, Jelovac D, Thiantanawat A, Brodie AM.
    Clin Cancer Res; 2002 Jul 15; 8(7):2378-88. PubMed ID: 12114443
    [Abstract] [Full Text] [Related]

  • 9. A mouse mammary tumor virus-Wnt-1 transgene induces mammary gland hyperplasia and tumorigenesis in mice lacking estrogen receptor-alpha.
    Bocchinfuso WP, Hively WP, Couse JF, Varmus HE, Korach KS.
    Cancer Res; 1999 Apr 15; 59(8):1869-76. PubMed ID: 10213494
    [Abstract] [Full Text] [Related]

  • 10. Aromatase overexpression induces malignant changes in estrogen receptor α negative MCF-10A cells.
    Wang J, Gildea JJ, Yue W.
    Oncogene; 2013 Oct 31; 32(44):5233-40. PubMed ID: 23178495
    [Abstract] [Full Text] [Related]

  • 11. Adaptive hypersensitivity to estrogen: mechanisms and clinical relevance to aromatase inhibitor therapy in breast cancer treatment.
    Santen RJ, Song RX, Zhang Z, Kumar R, Jeng MH, Masamura S, Lawrence J, MacMahon LP, Yue W, Berstein L.
    J Steroid Biochem Mol Biol; 2005 May 31; 95(1-5):155-65. PubMed ID: 16024245
    [Abstract] [Full Text] [Related]

  • 12. Catechol estrogen metabolites and conjugates in mammary tumors and hyperplastic tissue from estrogen receptor-alpha knock-out (ERKO)/Wnt-1 mice: implications for initiation of mammary tumors.
    Devanesan P, Santen RJ, Bocchinfuso WP, Korach KS, Rogan EG, Cavalieri E.
    Carcinogenesis; 2001 Sep 31; 22(9):1573-6. PubMed ID: 11532882
    [Abstract] [Full Text] [Related]

  • 13. Breast cancer aromatase expression evaluated by the novel antibody 677: correlations to intra-tumor estrogen levels and hormone receptor status.
    Geisler J, Suzuki T, Helle H, Miki Y, Nagasaki S, Duong NK, Ekse D, Aas T, Evans DB, Lønning PE, Sasano H.
    J Steroid Biochem Mol Biol; 2010 Feb 28; 118(4-5):237-41. PubMed ID: 19883757
    [Abstract] [Full Text] [Related]

  • 14. Estrogen and growth factor receptor interactions in human breast and non-small cell lung cancer cells.
    Pietras RJ, Márquez DC, Chen HW, Tsai E, Weinberg O, Fishbein M.
    Steroids; 2005 Feb 28; 70(5-7):372-81. PubMed ID: 15862820
    [Abstract] [Full Text] [Related]

  • 15. Oral fluoropyrimidine may augment the efficacy of aromatase inhibitor via the down-regulation of estrogen receptor in estrogen-responsive breast cancer xenografts.
    Nukatsuka M, Saito H, Nakagawa F, Abe M, Uchida J, Shibata J, Matsuo K, Noguchi S, Kiniwa M.
    Breast Cancer Res Treat; 2011 Jul 28; 128(2):381-90. PubMed ID: 20809360
    [Abstract] [Full Text] [Related]

  • 16. Aromatase expression increases the survival and malignancy of estrogen receptor positive breast cancer cells.
    Mukhopadhyay KD, Liu Z, Bandyopadhyay A, Kirma NB, Tekmal RR, Wang S, Sun LZ.
    PLoS One; 2015 Jul 28; 10(4):e0121136. PubMed ID: 25837259
    [Abstract] [Full Text] [Related]

  • 17. Estrogen receptor alpha is required for mammary development and the induction of mammary hyperplasia and epigenetic alterations in the aromatase transgenic mice.
    Tekmal RR, Liu YG, Nair HB, Jones J, Perla RP, Lubahn DB, Korach KS, Kirma N.
    J Steroid Biochem Mol Biol; 2005 May 28; 95(1-5):9-15. PubMed ID: 15955696
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of estrogen carcinogenesis: The role of E2/E1-quinone metabolites suggests new approaches to preventive intervention--A review.
    Yager JD.
    Steroids; 2015 Jul 28; 99(Pt A):56-60. PubMed ID: 25159108
    [Abstract] [Full Text] [Related]

  • 19. Aromatase inhibitors: rationale for use following antiestrogen therapy.
    Yue W, Santen RJ.
    Semin Oncol; 1996 Aug 28; 23(4 Suppl 9):21-7. PubMed ID: 8824461
    [Abstract] [Full Text] [Related]

  • 20. Functional implications of antiestrogen induction of quinone reductase: inhibition of estrogen-induced deoxyribonucleic acid damage.
    Bianco NR, Perry G, Smith MA, Templeton DJ, Montano MM.
    Mol Endocrinol; 2003 Jul 28; 17(7):1344-55. PubMed ID: 12714703
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.